Kobi Efraim - G Medical Controller

Insider

Kobi Efraim is Controller of G Medical Innovations
Age 68
Phone972 8 958 4777
Webhttps://gmedinnovations.com

G Medical Management Efficiency

The company has return on total asset (ROA) of (1.2631) % which means that it has lost $1.2631 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (8.6521) %, meaning that it generated substantial loss on money invested by shareholders. G Medical's management efficiency ratios could be used to measure how well G Medical manages its routine affairs as well as how well it operates its assets and liabilities.
G Medical Innovations has accumulated 2.09 M in total debt. G Medical Innovations has a current ratio of 0.39, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about G Medical's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 5 records

INSIDER Age

Udi MDInspira Technologies Oxy
41
Dagi BenNoonInspira Technologies Oxy
49
FACP MDBriaCell Therapeutics Corp
78
Joe HayonInspira Technologies Oxy
51
Farrah DeanBriaCell Therapeutics Corp
N/A
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. G Medical Innovations Holdings Ltd was founded in 2014 and is based in Rehovot, Israel. G Medical is traded on NASDAQ Exchange in the United States. G Medical Innovations (GMVDW) is traded on NASDAQ Exchange in USA and employs 7 people.

Management Performance

G Medical Innovations Leadership Team

Elected by the shareholders, the G Medical's board of directors comprises two types of representatives: G Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GMVDW. The board's role is to monitor G Medical's management team and ensure that shareholders' interests are well served. G Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, G Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Oded Shahar, Sr Acquisition
Benny Tal, VP CTO
Kobi Efraim, Controller
Brett Tucker, Company Sec
Yacov Geva, CEO and President
Igor Bluvstein, Chief Officer
Dror NurielRoth, Ex Operations

GMVDW Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is G Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Consideration for investing in GMVDW Stock

If you are still planning to invest in G Medical Innovations check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the G Medical's history and understand the potential risks before investing.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance